Capital Research Global Investors Takeda Pharmaceutical CO LTD Transaction History
Capital Research Global Investors
- $479 Billion
- Q2 2025
A detailed history of Capital Research Global Investors transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Capital Research Global Investors holds 13,295,573 shares of TAK stock, worth $195 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,295,573
Previous 13,201,004
0.72%
Holding current value
$195 Million
Previous $196 Million
4.71%
% of portfolio
0.04%
Previous 0.04%
Shares
18 transactions
Others Institutions Holding TAK
# of Institutions
369Shares Held
73.1MCall Options Held
1.68MPut Options Held
157K-
Morgan Stanley New York, NY7.62MShares$111 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$65.8 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$58.9 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$54.3 Million0.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.3MShares$48.3 Million0.07% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $45.5B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...